AI-Powered Precision: Accelerating Personalized Cancer Vaccine Development

• Accelerating Neoantigen Discovery – How AI integrates genomic, transcriptomic, and immunological data to rapidly identify and prioritize tumor-specific targets
• Optimizing Vaccine Design – Using predictive models and adaptive strategies to anticipate immune response and iteratively refine personalized formulations
• Translating Innovation into Impact – Case studies where AI platforms have shortened development timelines, improved patient outcomes, and opened new horizons for immunotherapy

Speakers:

Prasun Chakraborty

Chief Executive Officer & Founder - Innovator

Genevation